U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
117091117091Overcoming Obstacles to Clinical Trials Enrollment Through a Navigator ProgramActive, not recruitingNo Results AvailableGenital Neoplasms, Female|Gynecologic Cancers|Breast CancerBehavioral: Navigator Supporthttps://ClinicalTrials.gov/show/NCT01032447
117092117092An 8-week, Open-label Study to Evaluate the Effect of Sertraline on Polysomnogram in Depressive Patients With InsomniaCompletedNo Results AvailableDepressionDrug: sertralinehttps://ClinicalTrials.gov/show/NCT01032434
117093117093Gonadal Steroid Manipulation and Personality Characteristics: Association With Mood Fluctuations and in Vitro Fertilization (IVF) OutcomesCompletedNo Results AvailableMood DisordersProcedure: IVF procedurehttps://ClinicalTrials.gov/show/NCT01032421
117094117094Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 InfectionCompletedNo Results AvailableH1N1 Influenza Virus|Human Immunodeficiency Virus Type 1 (HIV-1) InfectionBiological: Focetria®|Biological: Begrivac®https://ClinicalTrials.gov/show/NCT01032408
117095117095Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes MellitusCompletedNo Results AvailableH1N1 Influenza Virus|Chronic Pulmonary Disease|Chronic Heart Disease|Diabetes MellitusBiological: Focetria®|Biological: Fluad®|Biological: Begrivac®https://ClinicalTrials.gov/show/NCT01032395
117096117096Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)CompletedHas ResultsLeishmaniasis, CutaneousDrug: WR 279,396 (15% paromomycin + 0.5% gentamicin topical cream)|Drug: Paromomycin Alone Cream (15% paromomycin topical cream)https://ClinicalTrials.gov/show/NCT01032382
117097117097The Additive Effect of Cognitive Behavioral Treatment (CBT) to Conventional Weight Loss Intervention Program for Young Adults With Intellectual DisabilitiesNot yet recruitingNo Results AvailableOverweight|Obesity|Learning DisabilityOther: Nutritional intervention and physical activity|Other: Nutritional intervention, physical activity and behavioral treatmenthttps://ClinicalTrials.gov/show/NCT01032369
117098117098Dynasplint for Distal Radius FractureNot yet recruitingNo Results AvailableDistal Radius FractureDevice: Wrist Extension Dynasplinthttps://ClinicalTrials.gov/show/NCT01032356
117099117099An Immunonutritional Approach to the Prevention of Skin CancerCompletedNo Results AvailableSkin CancerDietary Supplement: Omega-3 PUFA|Dietary Supplement: Gelatinehttps://ClinicalTrials.gov/show/NCT01032343
117100117100Observation Versus Occlusion Therapy for Intermittent ExotropiaActive, not recruitingNo Results AvailableExotropiaDevice: occlusion treatmenthttps://ClinicalTrials.gov/show/NCT01032330
117101117101Study of a New Catheter Using Force Sensing Capabilities for the Treatment of Atrial Fibrillation and Ventricular TachycardiaCompletedNo Results AvailableAtrial Fibrillation|Ischemic Ventricular TachycardiaDevice: Radiofrequency Catheter Ablationhttps://ClinicalTrials.gov/show/NCT01032317
117102117102The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD)Active, not recruitingNo Results AvailableChronic Obstructive Pulmonary Disease (COPD)Drug: Erdosteine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01032304
117103117103A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal CancerTerminatedHas ResultsColorectal CancerDrug: cetuximab|Drug: lenalidomidehttps://ClinicalTrials.gov/show/NCT01032291
117104117104Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)Active, not recruitingNo Results AvailableCardiac Toxicity|Unspecified Adult Solid Tumor, Protocol SpecificOther: Laboratory Biomarker Analysis|Behavioral: Questionnaireshttps://ClinicalTrials.gov/show/NCT01032278
117105117105Web-based Management of Female Stress Urinary IncontinenceCompletedHas ResultsFemale Stress Urinary IncontinenceBehavioral: Web-based treatment with PFMT and elements of CBT|Behavioral: Pamphlet treatmenthttps://ClinicalTrials.gov/show/NCT01032265
117106117106Prevention of Falls in General Practitioner for Community-dwelling Older Adults [PreFalls]CompletedNo Results AvailableAccidental Falls/Prevention & Control|Risk Assessment|General Practitioner Education|Humans|Multicenter Study|Randomized Controlled TrialOther: Exercise interventionhttps://ClinicalTrials.gov/show/NCT01032252
117107117107SISTERS: Spasticity In Stroke Study - Randomized StudyRecruitingNo Results AvailableSevere SpasticityDrug: intrathecal baclofenhttps://ClinicalTrials.gov/show/NCT01032239
117108117108Evaluation of CNAP During AnesthesiaTerminatedNo Results AvailableGeneral Anesthesiahttps://ClinicalTrials.gov/show/NCT01032226
117109117109Effect of Magnesium Sulphate on CoagulationCompletedNo Results AvailableMyomaDrug: Magnesium Sulfate|Drug: normal salinehttps://ClinicalTrials.gov/show/NCT01032213
117110117110Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain TumorsCompletedNo Results AvailableBrain Tumors|Nervous System Tumors|Cognition Disorders|FatigueDrug: Armodafinil|Other: placebohttps://ClinicalTrials.gov/show/NCT01032200
117111117111Amphotericin B to Treat Visceral Leishmaniasis in Brazilian ChildrenCompletedNo Results AvailableVisceral LeishmaniasisDrug: Meglumine antimoniate|Drug: Amphotericin B-deoxycholatehttps://ClinicalTrials.gov/show/NCT01032187
117112117112Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary SinusitisCompletedHas ResultsMaxillary SinusitisDrug: Azithromycin SR|Drug: Amoxiclav 1000 mghttps://ClinicalTrials.gov/show/NCT01032174
117113117113Perioperative Risk Factors for Postoperative Delirium in ChildrenCompletedNo Results AvailableDelirium, Postoperativehttps://ClinicalTrials.gov/show/NCT01032161
117114117114Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's LymphomaRecruitingNo Results AvailableHodgkin's Lymphoma|Non-Hodgkin's LymphomaDrug: LBH589https://ClinicalTrials.gov/show/NCT01032148
117115117115Adaptive Treatment for Cocaine DependenceActive, not recruitingNo Results AvailableCocaine DependenceBehavioral: Motivational Interviewing|Behavioral: Telephone counseling|Behavioral: Cognitive Behavioral Therapy (CBT) Counselinghttps://ClinicalTrials.gov/show/NCT01032135
117116117116Rituximab in Metastatic MelanomaTerminatedNo Results AvailableMetastatic MelanomaDrug: rituximabhttps://ClinicalTrials.gov/show/NCT01032122
117117117117Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular DegenerationCompletedNo Results AvailableAge-Related Macular DegenerationDrug: Bevacizumabhttps://ClinicalTrials.gov/show/NCT01032109
117118117118The Physiological Response to Routine Head and Neck Cancer SurgeryRecruitingNo Results AvailableHead and Neck Cancerhttps://ClinicalTrials.gov/show/NCT01032096
117119117119Antidepressant Controlled Trial for Negative Symptoms in SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Citalopram|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01032083
117120117120Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric EpendymomaTerminatedHas ResultsRecurrent or Refractory Pediatric EpendymomaDrug: erlotinib|Drug: etoposidehttps://ClinicalTrials.gov/show/NCT01032070

* Görseller ve İçerik tekif hakkına sahip olabilir